Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
eribulin
×
Clear all
Filters
3
NCT02555657
2021-12-10
KEYNOTE-119
Merck Sharp & Dohme LLC
Phase 3
Completed
622 enrolled
26 charts